Filing Details

Accession Number:
0001011438-25-000122
Form Type:
13G Filing
Publication Date:
2025-02-12 19:00:00
Filed By:
Cadian Capital
Company:
Maxcyte Inc.
Filing Date:
2025-02-13
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
Cadian Capital Management, LP 0 9,344,424 8.9%
Cadian Capital Management GP, LLC 0 9,344,424 8.9%
ERIC BANNASCH 0 9,344,424 8.9%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G


 
Cadian Capital Management, LP
 
Signature:/s/ Eric Bannasch
Name/Title:Eric Bannasch/Managing Member, Cadian Capital Management GP, LLC, its General Partner
Date:02/13/2025
 
Cadian Capital Management GP, LLC
 
Signature:/s/ Eric Bannasch
Name/Title:Eric Bannasch/Managing Member
Date:02/13/2025
 
ERIC BANNASCH
 
Signature:/s/ Eric Bannasch
Name/Title:Eric Bannasch/Self
Date:02/13/2025